Otsuka Pharmaceutical India

Otsuka Pharmaceutical India Private Limited (OPIPL) is a leading healthcare company specializing in the manufacture and marketing of intravenous (IV) fluids, clinical nutrition, and therapeutic drugs. Headquartered in Ahmedabad, Gujarat, the company was established as a joint venture before becoming a subsidiary of the Japanese multinational Otsuka Pharmaceutical Co., Ltd. OPIPL operates a state-of-the-art manufacturing facility utilizing advanced Blow-Fill-Seal (BFS) technology to produce a wide range of products, including basic infusions, electrolyte replacements, and plasma expanders. The company serves both the domestic Indian market and numerous international territories, focusing on critical care, gastroenterology, and anti-infectives. Their commitment to global quality standards has made them a key player in the infusion therapy and clinical nutrition sectors.